Literature DB >> 28574182

Optimizing the combination insulin bolus split for a high-fat, high-protein meal in children and adolescents using insulin pump therapy.

P E Lopez1,2,3,4, C E Smart1,2,4, P McElduff2,3, D C Foskett5, D A Price6,7,8, M A Paterson1,2,3,4, B R King1,2,3,4.   

Abstract

AIMS: To determine the optimum combination bolus split to maintain postprandial glycaemia with a high-fat and high-protein meal in young people with Type 1 diabetes.
METHODS: A total of 19 young people (mean age 12.9 ± 6.7 years) participated in a randomized, repeated-measures trial comparing postprandial glycaemic control across six study conditions after a high-fat and high-protein meal. A standard bolus and five different combination boluses were delivered over 2 h in the following splits: 70/30 = 70% standard /30% extended bolus; 60/40=60% standard/40% extended bolus; 50/50=50% standard/50% extended bolus; 40/60=40% standard/60% extended bolus; and 30/70=30% standard/70% extended bolus. Insulin dose was determined using the participant's optimized insulin:carbohydrate ratio. Continuous glucose monitoring was used to assess glucose excursions for 6 h after the test meal.
RESULTS: Standard bolus and combination boluses 70/30 and 60/40 controlled the glucose excursion up to 120 min. From 240 to 300 min after the meal, the glucose area under the curve was significantly lower for combination bolus 30/70 compared with standard bolus (P=0.004).
CONCLUSIONS: High-fat and high-protein meals require a ≥60% insulin:carbohydrate ratio as a standard bolus to control the initial postprandial rise. Additional insulin at an insulin:carbohydrate ratio of up to 70% is needed in the extended bolus for a high fat and protein meal to prevent delayed hyperglycaemia.
© 2017 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28574182     DOI: 10.1111/dme.13392

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  Factors Beyond Carbohydrate to Consider When Determining Meantime Insulin Doses: Protein, Fat, Timing, and Technology.

Authors:  Alison B Evert
Journal:  Diabetes Spectr       Date:  2020-05

Review 2.  Use of fast-acting insulin aspart in insulin pump therapy in clinical practice.

Authors:  Mark Evans; Antonio Ceriello; Thomas Danne; Christophe De Block; J Hans DeVries; Marcus Lind; Chantal Mathieu; Kirsten Nørgaard; Eric Renard; Emma G Wilmot
Journal:  Diabetes Obes Metab       Date:  2019-06-19       Impact factor: 6.577

Review 3.  Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report.

Authors:  Alison B Evert; Michelle Dennison; Christopher D Gardner; W Timothy Garvey; Ka Hei Karen Lau; Janice MacLeod; Joanna Mitri; Raquel F Pereira; Kelly Rawlings; Shamera Robinson; Laura Saslow; Sacha Uelmen; Patricia B Urbanski; William S Yancy
Journal:  Diabetes Care       Date:  2019-04-18       Impact factor: 19.112

4.  Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems.

Authors:  Brynn E Marks; Kristen M Williams; Jordan S Sherwood; Melissa S Putman
Journal:  J Clin Transl Endocrinol       Date:  2021-12-04

5.  Decreased Need for Correction Boluses with Universal Utilisation of Dual-Wave Boluses in Children with Type 1 Diabetes.

Authors:  Mari Lukka; Vallo Tillmann; Aleksandr Peet
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.